Locus Biosciences' Series A Round

Locus Biosciences raised a round of funding on October 02, 2017.

Locus Biosciences is a biotechnology company focusing on the discovery and development of a CRISPR-Cas platform for precision antimicrobials. The company designs and creates novel CRISPR RNAs (guide R…

Articles about Locus Biosciences' Series A Round: